Portosystemic Shunt Evaluation and Management in Canine Medicine

Portosystemic shunts in dogs represent aberrant vascular connections that divert portal blood away from the hepatic parenchyma, leading to reduced hepatic detoxification and metabolic function. These shunts may be congenital or acquired, and are broadly categorised as intrahepatic or extrahepatic based on their anatomical localisation. Clinical presentation is variable, ranging from subtle behavioural changes and intermittent gastrointestinal signs to overt hepatic encephalopathy characterised by neurological dysfunction. Initial evaluation typically employs ultrasonography to detect abnormal vessels and assess flow dynamics, often supplemented by contrast‐enhanced computed tomography angiography for precise anatomical mapping. Management strategies include surgical attenuation of the shunt—using techniques such as ameroid ring constrictors, cellophane banding or percutaneous transvenous coil embolisation—or medical therapy involving dietary protein restriction, non‐absorbable disaccharides and targeted antibiotic use to reduce systemic toxin levels. Postoperative care demands close monitoring for complications such as postattenuation neurological signs and portal hypertension. Long‐term prognosis is generally favourable in dogs following successful shunt attenuation, though individual outcomes depend on shunt type, preoperative hepatic function and the presence of comorbidities.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Portosystemic Shunt Evaluation and Management in Canine Medicine publication trend

The graph below shows the total number of articles in portosystemic shunt evaluation and management in canine medicine across all publications each year (not limited to Nature Index journals).

Technical terms

Portosystemic shunt: An abnormal vascular channel that allows portal blood to bypass the liver and enter systemic circulation directly.

Intrahepatic: Referring to shunts located within the liver parenchyma, typically connecting portal vessels to intrahepatic venous channels.

Extrahepatic: Referring to shunts located outside the liver, often forming a connection between the portal vein and systemic veins such as the vena cava.

Attenuation: The surgical or interventional reduction of shunt blood flow, achieved gradually or acutely to restore portal perfusion.

Ameroid ring constrictor: A device implanted around the shunt vessel that swells over time to gradually occlude the aberrant connection.

Hepatic encephalopathy: A spectrum of neurological disturbances caused by accumulation of neurotoxins, notably ammonia, due to impaired liver detoxification.

CT angiography: A radiological technique using contrast medium and computed tomography to visualise vascular anatomy and flow in three dimensions.

References

1. Radiologic Evaluation of Portosystemic Shunts in Humans and Small Animals: Review of the Literature with Clinical Case Reports. Diagnostics (2023).
2. Anomalies of the Portal Venous System in Dogs and Cats as Seen on Multidetector-Row Computed Tomography: An Overview and Systematization Proposal. Veterinary Sciences (2019).
3. Congenital Portosystemic Shunts in Dogs and Cats: Classification, Pathophysiology, Clinical Presentation and Diagnosis. Veterinary Sciences (2023).
4. Distribution of extrahepatic congenital portosystemic shunt morphology in predisposed dog breeds. BMC Veterinary Research (2012).
5. Canine intrahepatic portosystemic shunt insertion into the systemic circulation is commonly through primary hepatic veins as assessed with CT angiography. Veterinary Radiology & Ultrasound (2020).
6. Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts. Veterinary Quarterly (2020).
7. Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis. Veterinary Sciences (2023).